Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Robert A. Lasser, MD
JCP
Original Research
Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled Study
July 15, 2013
Lenard A. Adler
,
Bryan Dirks
,
Patrick F. Deas
, et al
JCP
Original Research
Lifespan Persistence of ADHD: The Life Transition Model and Its Application
January 10, 2012
Atilla Turgay
,
David W. Goodman
,
Philip Asherson
, et al
JCP
Original Research
A 1-Year Double-Blind Study of 2 Doses of Long-Acting Risperidone in Stable Patients With Schizophrenia or Schizoaffective Disorder.
August 15, 2006
George M. Simpson
,
Ramy A. Mahmoud
,
Robert A. Lasser
, et al
JCP
Letter to the Editor
Methodological Issues in a Comparative Study of Ziprasidone and Risperidone
January 16, 2006
Georges M. Gharabawi
,
Cynthia A. Bossie
,
Ramy Mahmoud
, et al
JCP
Original Research
Combining Serotonin Reuptake Inhibitors and Bupropion in Partial Responders to Antidepressant Monotherapy
April 15, 1997
J. Alexander Bodkin
,
Robert A. Lasser
,
James D. Wines, Jr.
, et al
